These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1573833)

  • 1. Platelet-derived growth factor: a potentially important cytokine in glomerular disease.
    Johnson R; Iida H; Yoshimura A; Floege J; Bowen-Pope DF
    Kidney Int; 1992 Mar; 41(3):590-4. PubMed ID: 1573833
    [No Abstract]   [Full Text] [Related]  

  • 2. Is mesangial cell proliferation required for extracellular matrix expansion in glomerular disease?
    Eng E; Floege J; Young BA; Alpers CE; Couser WG; Johnson RJ
    Contrib Nephrol; 1994; 107():156-62. PubMed ID: 8004962
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor.
    Johnson RJ; Raines EW; Floege J; Yoshimura A; Pritzl P; Alpers C; Ross R
    J Exp Med; 1992 May; 175(5):1413-6. PubMed ID: 1569407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of platelet-derived growth factor in progression of nephropathy].
    Spustová V; Oksa A; Dzúrik R
    Vnitr Lek; 1996 Dec; 42(12):842-8. PubMed ID: 9072884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple roles for platelet-derived growth factor in renal disease.
    Floege J; Johnson RJ
    Miner Electrolyte Metab; 1995; 21(4-5):271-82. PubMed ID: 7565476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat.
    Iida H; Seifert R; Alpers CE; Gronwald RG; Phillips PE; Pritzl P; Gordon K; Gown AM; Ross R; Bowen-Pope DF
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6560-4. PubMed ID: 1713682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor mesangial deposits in mesangial IgA glomerulonephritis.
    Nakajima M; Hewitson TD; Mathews DC; Kincaid-Smith P
    Nephrol Dial Transplant; 1991; 6(1):11-6. PubMed ID: 2057110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.
    Pichler RH; Bassuk JA; Hugo C; Reed MJ; Eng E; Gordon KL; Pippin J; Alpers CE; Couser WG; Sage EH; Johnson RJ
    Am J Pathol; 1996 Apr; 148(4):1153-67. PubMed ID: 8644857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine networks and the pathogenesis of glomerulonephritis.
    Johnson RJ
    J Lab Clin Med; 1993 Feb; 121(2):190-2. PubMed ID: 8433031
    [No Abstract]   [Full Text] [Related]  

  • 10. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
    Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
    Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor and proliferative glomerulonephritis.
    Gesualdo L; Ranieri E; Pannarale G; Di Paolo S; Schena FP
    Kidney Int Suppl; 1993 Jan; 39():S86-9. PubMed ID: 8468932
    [No Abstract]   [Full Text] [Related]  

  • 12. Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis.
    Barnes JL; Abboud HE
    Am J Pathol; 1993 Nov; 143(5):1366-76. PubMed ID: 8238253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Various types of glomerulonephritis. Membranoproliferative glomerulonephritis].
    Saito T; Seino J; Sato H; Kinoshita Y; Akiu N; Ootaka T; Horigome I
    Nihon Rinsho; 1988 Jun; 46(6):1273-8. PubMed ID: 3418894
    [No Abstract]   [Full Text] [Related]  

  • 14. Focal mesangial proliferative glomerulonephritis in the rat caused by habu snake venom. A morphologic study.
    Cattell V; Bradfield JW
    Am J Pathol; 1977 Jun; 87(3):511-24. PubMed ID: 869011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cytokines in inflammatory glomerular injury.
    Lakkis FG; Coêlho SN
    Miner Electrolyte Metab; 1995; 21(4-5):250-61. PubMed ID: 7565474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis.
    Bessho K; Mizuno S; Matsumoto K; Nakamura T
    Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1171-80. PubMed ID: 12595276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3 mesangial proliferative glomerulonephritis--an evaluation of acute poststreptococcal glomerulonephritis?
    Deliyska B; Minkova V; Nikolov D; Tishkov I
    Clin Nephrol; 1997 Dec; 48(6):390. PubMed ID: 9518184
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth factors and their receptors in the progression of renal damage.
    Gesualdo L; Di Paolo S; Ranieri E; Schena FP
    Contrib Nephrol; 1995; 111():38-44. PubMed ID: 7758345
    [No Abstract]   [Full Text] [Related]  

  • 19. Amelioration of habu venom-induced glomerular lesions: potential role for platelet secretory proteins.
    Barnes JL
    J Lab Clin Med; 1989 Aug; 114(2):200-6. PubMed ID: 2754307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of atherosclerosis and blood platelets: platelet-derived growth factor and atherosclerosis].
    Kawahara Y; Kariya K; Fukuzaki H
    Nihon Rinsho; 1988 Mar; 46(3):565-73. PubMed ID: 3404683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.